Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for PAX5
Z-value: 1.84
Motif logo
Transcription factors associated with PAX5
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PAX5
|
ENSG00000196092.8 | paired box 5 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PAX5 | hg19_v2_chr9_-_37034028_37034157 | 0.55 | 1.6e-18 | Click! |
Activity profile of PAX5 motif
Sorted Z-values of PAX5 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_106069247 | 42.50 |
ENST00000479229.1
|
RP11-731F5.1
|
RP11-731F5.1 |
| chr9_+_139874683 | 40.04 |
ENST00000444903.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr9_+_139873264 | 31.18 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr9_+_139871948 | 25.79 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr22_+_23101182 | 25.21 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr2_+_89986318 | 23.47 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
| chr22_+_23040274 | 22.23 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr17_-_42992856 | 19.41 |
ENST00000588316.1
ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP
|
glial fibrillary acidic protein |
| chr16_+_85942594 | 18.69 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
| chr16_+_226658 | 18.36 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
| chr22_+_23165153 | 18.31 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr17_+_1674982 | 17.37 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr9_+_74526384 | 17.19 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
| chr11_-_5248294 | 17.06 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
| chr17_-_42580738 | 16.58 |
ENST00000585614.1
ENST00000591680.1 ENST00000434000.1 ENST00000588554.1 ENST00000592154.1 |
GPATCH8
|
G patch domain containing 8 |
| chr18_-_74728998 | 16.03 |
ENST00000359645.3
ENST00000397875.3 ENST00000397869.3 ENST00000578193.1 ENST00000578873.1 ENST00000397866.4 ENST00000528160.1 ENST00000527041.1 ENST00000526111.1 ENST00000397865.5 ENST00000382582.3 |
MBP
|
myelin basic protein |
| chr4_-_57524061 | 15.90 |
ENST00000508121.1
|
HOPX
|
HOP homeobox |
| chr17_-_79105734 | 15.70 |
ENST00000417379.1
|
AATK
|
apoptosis-associated tyrosine kinase |
| chrX_+_129473859 | 15.55 |
ENST00000424447.1
|
SLC25A14
|
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
| chr2_-_11272234 | 15.50 |
ENST00000590207.1
ENST00000417697.2 ENST00000396164.1 ENST00000536743.1 ENST00000544306.1 |
AC062028.1
|
AC062028.1 |
| chr3_-_58572760 | 15.44 |
ENST00000447756.2
|
FAM107A
|
family with sequence similarity 107, member A |
| chr1_+_10270863 | 15.36 |
ENST00000377093.4
ENST00000263934.6 |
KIF1B
|
kinesin family member 1B |
| chr19_+_47852538 | 15.17 |
ENST00000328771.4
|
DHX34
|
DEAH (Asp-Glu-Ala-His) box polypeptide 34 |
| chr20_+_46130671 | 15.16 |
ENST00000371998.3
ENST00000371997.3 |
NCOA3
|
nuclear receptor coactivator 3 |
| chr6_-_84419101 | 15.06 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr3_-_58613323 | 15.06 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
| chr5_-_139944196 | 15.05 |
ENST00000357560.4
|
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
| chr19_+_18208603 | 14.91 |
ENST00000262811.6
|
MAST3
|
microtubule associated serine/threonine kinase 3 |
| chr2_+_89901292 | 14.86 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr10_+_76871353 | 14.43 |
ENST00000542569.1
|
SAMD8
|
sterile alpha motif domain containing 8 |
| chr12_+_53773944 | 14.35 |
ENST00000551969.1
ENST00000327443.4 |
SP1
|
Sp1 transcription factor |
| chr6_-_46459675 | 14.24 |
ENST00000306764.7
|
RCAN2
|
regulator of calcineurin 2 |
| chr20_+_49575342 | 14.16 |
ENST00000244051.1
|
MOCS3
|
molybdenum cofactor synthesis 3 |
| chr9_+_33290491 | 14.15 |
ENST00000379540.3
ENST00000379521.4 ENST00000318524.6 |
NFX1
|
nuclear transcription factor, X-box binding 1 |
| chr7_-_129845313 | 14.12 |
ENST00000397622.2
|
TMEM209
|
transmembrane protein 209 |
| chr12_-_91539918 | 14.10 |
ENST00000548218.1
|
DCN
|
decorin |
| chr7_+_77325738 | 14.03 |
ENST00000334955.8
|
RSBN1L
|
round spermatid basic protein 1-like |
| chr14_-_77843390 | 13.49 |
ENST00000216468.7
|
TMED8
|
transmembrane emp24 protein transport domain containing 8 |
| chr22_-_37882395 | 13.36 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr7_-_129845188 | 13.25 |
ENST00000462753.1
ENST00000471077.1 ENST00000473456.1 ENST00000336804.8 |
TMEM209
|
transmembrane protein 209 |
| chr1_-_160001737 | 13.18 |
ENST00000368090.2
|
PIGM
|
phosphatidylinositol glycan anchor biosynthesis, class M |
| chr1_+_46668994 | 13.09 |
ENST00000371980.3
|
LURAP1
|
leucine rich adaptor protein 1 |
| chr19_-_18314836 | 13.03 |
ENST00000464076.3
ENST00000222256.4 |
RAB3A
|
RAB3A, member RAS oncogene family |
| chr12_-_53601000 | 13.03 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
| chr19_+_41284121 | 13.00 |
ENST00000594800.1
ENST00000357052.2 ENST00000602173.1 |
RAB4B
|
RAB4B, member RAS oncogene family |
| chr3_+_14989186 | 12.91 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
| chr5_-_139943830 | 12.71 |
ENST00000412920.3
ENST00000511201.2 ENST00000356738.2 ENST00000354402.5 ENST00000358580.5 ENST00000508496.2 |
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
| chr14_-_106174960 | 12.69 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
| chr19_-_48018203 | 12.68 |
ENST00000595227.1
ENST00000593761.1 ENST00000263354.3 |
NAPA
|
N-ethylmaleimide-sensitive factor attachment protein, alpha |
| chr6_-_32634425 | 12.67 |
ENST00000399082.3
ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
| chr17_+_74733744 | 12.65 |
ENST00000586689.1
ENST00000587661.1 ENST00000593181.1 ENST00000336509.4 ENST00000355954.3 |
MFSD11
|
major facilitator superfamily domain containing 11 |
| chr10_+_76871454 | 12.64 |
ENST00000372687.4
|
SAMD8
|
sterile alpha motif domain containing 8 |
| chr16_+_222846 | 12.36 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
| chr14_-_89878369 | 12.34 |
ENST00000553840.1
ENST00000556916.1 |
FOXN3
|
forkhead box N3 |
| chr11_-_125366089 | 12.21 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chr11_+_28129795 | 12.18 |
ENST00000406787.3
ENST00000342303.5 ENST00000403099.1 ENST00000407364.3 |
METTL15
|
methyltransferase like 15 |
| chr4_+_48018781 | 12.12 |
ENST00000295461.5
|
NIPAL1
|
NIPA-like domain containing 1 |
| chr1_-_27961720 | 11.88 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
| chr19_+_42817527 | 11.86 |
ENST00000598766.1
|
TMEM145
|
transmembrane protein 145 |
| chr14_-_106622419 | 11.79 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
| chr3_-_48057890 | 11.72 |
ENST00000434267.1
|
MAP4
|
microtubule-associated protein 4 |
| chr7_+_102715315 | 11.72 |
ENST00000428183.2
ENST00000323716.3 ENST00000441711.2 ENST00000454559.1 ENST00000425331.1 ENST00000541300.1 |
ARMC10
|
armadillo repeat containing 10 |
| chr3_+_10206545 | 11.71 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
| chr22_-_45559642 | 11.66 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
| chr1_+_160085501 | 11.63 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr1_+_160097462 | 11.52 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chrX_-_50557014 | 11.37 |
ENST00000376020.2
|
SHROOM4
|
shroom family member 4 |
| chr11_+_62475130 | 11.35 |
ENST00000294117.5
|
GNG3
|
guanine nucleotide binding protein (G protein), gamma 3 |
| chr6_+_32407619 | 11.17 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
| chr19_+_36195467 | 11.13 |
ENST00000426659.2
|
ZBTB32
|
zinc finger and BTB domain containing 32 |
| chr16_+_67840986 | 11.09 |
ENST00000561639.1
ENST00000567852.1 ENST00000565148.1 ENST00000388833.3 ENST00000561654.1 ENST00000431934.2 |
TSNAXIP1
|
translin-associated factor X interacting protein 1 |
| chr20_-_35492048 | 11.09 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
| chr11_+_2421718 | 11.04 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
| chr2_+_89999259 | 11.03 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr6_-_46459099 | 11.00 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
| chr14_-_106963409 | 10.97 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
| chr22_+_22930626 | 10.97 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr17_+_1665345 | 10.97 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr22_+_23264766 | 10.88 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chrX_-_50557302 | 10.83 |
ENST00000289292.7
|
SHROOM4
|
shroom family member 4 |
| chr3_-_195310802 | 10.79 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
| chr19_+_58095501 | 10.78 |
ENST00000536878.2
ENST00000597850.1 ENST00000597219.1 ENST00000598689.1 ENST00000599456.1 ENST00000307468.4 |
ZIK1
|
zinc finger protein interacting with K protein 1 |
| chr19_-_49828438 | 10.75 |
ENST00000454748.3
ENST00000598828.1 ENST00000335875.4 |
SLC6A16
|
solute carrier family 6, member 16 |
| chrX_-_13956737 | 10.75 |
ENST00000454189.2
|
GPM6B
|
glycoprotein M6B |
| chr21_+_41239243 | 10.70 |
ENST00000328619.5
|
PCP4
|
Purkinje cell protein 4 |
| chr6_+_111580508 | 10.62 |
ENST00000368847.4
|
KIAA1919
|
KIAA1919 |
| chr7_-_87505658 | 10.54 |
ENST00000341119.5
|
SLC25A40
|
solute carrier family 25, member 40 |
| chr5_-_149792295 | 10.53 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
| chr4_-_57522598 | 10.44 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
| chr11_+_117857063 | 10.44 |
ENST00000227752.3
ENST00000541785.1 ENST00000545409.1 |
IL10RA
|
interleukin 10 receptor, alpha |
| chr22_+_22786288 | 10.40 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr1_+_111773349 | 10.34 |
ENST00000533831.2
|
CHI3L2
|
chitinase 3-like 2 |
| chr11_+_1891380 | 10.33 |
ENST00000429923.1
ENST00000418975.1 ENST00000406638.2 |
LSP1
|
lymphocyte-specific protein 1 |
| chr4_-_57522673 | 10.32 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
| chr2_-_89399845 | 10.30 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr16_+_67840668 | 10.29 |
ENST00000415766.3
|
TSNAXIP1
|
translin-associated factor X interacting protein 1 |
| chr19_-_15529790 | 10.29 |
ENST00000596195.1
ENST00000595067.1 ENST00000595465.2 ENST00000397410.5 ENST00000600247.1 |
AKAP8L
|
A kinase (PRKA) anchor protein 8-like |
| chr6_-_41701581 | 10.19 |
ENST00000394283.1
|
TFEB
|
transcription factor EB |
| chr11_+_62439126 | 10.17 |
ENST00000377953.3
|
C11orf83
|
chromosome 11 open reading frame 83 |
| chr2_-_89619904 | 10.15 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr17_-_2415169 | 10.13 |
ENST00000263092.6
ENST00000538844.1 ENST00000576976.1 |
METTL16
|
methyltransferase like 16 |
| chr5_-_79551838 | 10.12 |
ENST00000509193.1
ENST00000512972.2 |
SERINC5
|
serine incorporator 5 |
| chr5_-_127418755 | 10.11 |
ENST00000501702.2
ENST00000501173.2 ENST00000514573.1 ENST00000499346.2 ENST00000606251.1 |
CTC-228N24.3
|
CTC-228N24.3 |
| chr15_-_43941023 | 10.10 |
ENST00000432420.1
ENST00000321596.5 ENST00000354127.4 ENST00000355438.2 ENST00000396879.1 ENST00000381761.1 |
CATSPER2
|
cation channel, sperm associated 2 |
| chr1_-_182360498 | 10.10 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
| chr7_+_156742399 | 10.09 |
ENST00000275820.3
|
NOM1
|
nucleolar protein with MIF4G domain 1 |
| chr6_-_32908765 | 10.07 |
ENST00000416244.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
| chr2_-_85839146 | 10.05 |
ENST00000306336.5
ENST00000409734.3 |
C2orf68
|
chromosome 2 open reading frame 68 |
| chr14_-_106539557 | 10.03 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr14_-_21493884 | 10.03 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
| chr20_+_5892037 | 9.96 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
| chr2_-_99224915 | 9.95 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
| chr15_-_48470558 | 9.94 |
ENST00000324324.7
|
MYEF2
|
myelin expression factor 2 |
| chr2_-_89157161 | 9.90 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
| chr1_+_33352036 | 9.89 |
ENST00000373467.3
|
HPCA
|
hippocalcin |
| chr7_+_30951461 | 9.89 |
ENST00000311813.4
|
AQP1
|
aquaporin 1 (Colton blood group) |
| chr12_+_106696581 | 9.86 |
ENST00000547153.1
ENST00000299045.3 ENST00000546625.1 ENST00000553098.1 |
TCP11L2
|
t-complex 11, testis-specific-like 2 |
| chr8_+_21912328 | 9.78 |
ENST00000432128.1
ENST00000443491.2 ENST00000517600.1 ENST00000523782.2 |
DMTN
|
dematin actin binding protein |
| chr1_-_32210275 | 9.76 |
ENST00000440175.2
|
BAI2
|
brain-specific angiogenesis inhibitor 2 |
| chr3_+_156544057 | 9.75 |
ENST00000498839.1
ENST00000470811.1 ENST00000356539.4 ENST00000483177.1 ENST00000477399.1 ENST00000491763.1 |
LEKR1
|
leucine, glutamate and lysine rich 1 |
| chr3_-_58563094 | 9.75 |
ENST00000464064.1
|
FAM107A
|
family with sequence similarity 107, member A |
| chr10_+_43916052 | 9.74 |
ENST00000442526.2
|
RP11-517P14.2
|
RP11-517P14.2 |
| chr1_+_159175201 | 9.73 |
ENST00000368121.2
|
DARC
|
Duffy blood group, atypical chemokine receptor |
| chr3_-_169899504 | 9.69 |
ENST00000474275.1
ENST00000484931.1 ENST00000494943.1 ENST00000497658.1 ENST00000465896.1 ENST00000475729.1 ENST00000495893.2 ENST00000481639.1 ENST00000467570.1 ENST00000466189.1 |
PHC3
|
polyhomeotic homolog 3 (Drosophila) |
| chr12_-_51717948 | 9.68 |
ENST00000267012.4
|
BIN2
|
bridging integrator 2 |
| chr11_+_113258495 | 9.66 |
ENST00000303941.3
|
ANKK1
|
ankyrin repeat and kinase domain containing 1 |
| chr19_+_57831829 | 9.63 |
ENST00000321545.4
|
ZNF543
|
zinc finger protein 543 |
| chr5_+_55033845 | 9.60 |
ENST00000353507.5
ENST00000514278.2 ENST00000505374.1 ENST00000506511.1 |
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
| chr3_+_57541975 | 9.56 |
ENST00000487257.1
ENST00000311180.8 |
PDE12
|
phosphodiesterase 12 |
| chr19_-_2702681 | 9.55 |
ENST00000382159.3
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7 |
| chr20_+_46130619 | 9.54 |
ENST00000372004.3
|
NCOA3
|
nuclear receptor coactivator 3 |
| chr20_+_55904815 | 9.54 |
ENST00000371263.3
ENST00000345868.4 ENST00000371260.4 ENST00000418127.1 |
SPO11
|
SPO11 meiotic protein covalently bound to DSB |
| chr19_+_36195429 | 9.46 |
ENST00000392197.2
|
ZBTB32
|
zinc finger and BTB domain containing 32 |
| chr3_-_138763734 | 9.45 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
| chr19_+_49838653 | 9.45 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chr14_-_21270995 | 9.43 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
| chr1_+_6845384 | 9.41 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr1_-_226111929 | 9.39 |
ENST00000343818.6
ENST00000432920.2 |
PYCR2
RP4-559A3.7
|
pyrroline-5-carboxylate reductase family, member 2 Uncharacterized protein |
| chr12_-_51717875 | 9.36 |
ENST00000604560.1
|
BIN2
|
bridging integrator 2 |
| chr3_-_39322728 | 9.35 |
ENST00000541347.1
ENST00000412814.1 |
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
| chr2_-_100939195 | 9.33 |
ENST00000393437.3
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
| chr2_-_89292422 | 9.32 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr12_-_53601055 | 9.32 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
| chr8_-_120685608 | 9.32 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
| chr3_+_197476621 | 9.30 |
ENST00000241502.4
|
FYTTD1
|
forty-two-three domain containing 1 |
| chr8_-_38386175 | 9.28 |
ENST00000437935.2
ENST00000358138.1 |
C8orf86
|
chromosome 8 open reading frame 86 |
| chr22_+_22712087 | 9.27 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
| chr8_+_21916680 | 9.27 |
ENST00000358242.3
ENST00000415253.1 |
DMTN
|
dematin actin binding protein |
| chr21_+_27011584 | 9.25 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
| chr20_-_47894936 | 9.21 |
ENST00000371754.4
|
ZNFX1
|
zinc finger, NFX1-type containing 1 |
| chr3_+_9404526 | 9.21 |
ENST00000452837.2
ENST00000417036.1 ENST00000419437.1 ENST00000345094.3 ENST00000515662.2 |
THUMPD3
|
THUMP domain containing 3 |
| chr16_-_11370330 | 9.19 |
ENST00000241808.4
ENST00000435245.2 |
PRM2
|
protamine 2 |
| chr14_-_106642049 | 9.17 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr13_+_114567131 | 9.13 |
ENST00000608651.1
|
GAS6-AS2
|
GAS6 antisense RNA 2 (head to head) |
| chr2_-_220110187 | 9.12 |
ENST00000295759.7
ENST00000392089.2 |
GLB1L
|
galactosidase, beta 1-like |
| chr2_-_68384603 | 9.11 |
ENST00000406245.2
ENST00000409164.1 ENST00000295121.6 |
WDR92
|
WD repeat domain 92 |
| chr19_-_54327542 | 9.10 |
ENST00000391775.3
ENST00000324134.6 ENST00000535162.1 ENST00000351894.4 ENST00000354278.3 ENST00000391773.1 ENST00000345770.5 ENST00000391772.1 |
NLRP12
|
NLR family, pyrin domain containing 12 |
| chr6_-_44281043 | 9.07 |
ENST00000244571.4
|
AARS2
|
alanyl-tRNA synthetase 2, mitochondrial |
| chr1_+_183441500 | 9.07 |
ENST00000456731.2
|
SMG7
|
SMG7 nonsense mediated mRNA decay factor |
| chr11_+_71791849 | 9.07 |
ENST00000423494.2
ENST00000539587.1 ENST00000538478.1 ENST00000324866.7 ENST00000439209.1 |
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing |
| chr9_-_124132483 | 9.04 |
ENST00000286713.2
ENST00000538954.1 ENST00000347359.2 |
STOM
|
stomatin |
| chr5_-_131132614 | 9.03 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
| chr6_-_31514333 | 9.03 |
ENST00000376151.4
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
| chr17_+_17942594 | 9.01 |
ENST00000268719.4
|
GID4
|
GID complex subunit 4 |
| chr9_+_130159409 | 9.00 |
ENST00000373371.3
|
SLC2A8
|
solute carrier family 2 (facilitated glucose transporter), member 8 |
| chr11_-_6440624 | 9.00 |
ENST00000311051.3
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
| chr10_+_126150369 | 8.99 |
ENST00000392757.4
ENST00000368842.5 ENST00000368839.1 |
LHPP
|
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
| chr12_-_51717922 | 8.99 |
ENST00000452142.2
|
BIN2
|
bridging integrator 2 |
| chr8_+_21916710 | 8.97 |
ENST00000523266.1
ENST00000519907.1 |
DMTN
|
dematin actin binding protein |
| chr3_-_16646949 | 8.96 |
ENST00000399444.2
|
DAZL
|
deleted in azoospermia-like |
| chr19_-_17185848 | 8.90 |
ENST00000593360.1
|
HAUS8
|
HAUS augmin-like complex, subunit 8 |
| chr14_-_21491477 | 8.90 |
ENST00000298684.5
ENST00000557169.1 ENST00000553563.1 |
NDRG2
|
NDRG family member 2 |
| chr1_+_27561104 | 8.89 |
ENST00000361771.3
|
WDTC1
|
WD and tetratricopeptide repeats 1 |
| chr22_-_19512893 | 8.87 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
| chr6_-_152639479 | 8.86 |
ENST00000356820.4
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1 |
| chr8_-_27457494 | 8.82 |
ENST00000521770.1
|
CLU
|
clusterin |
| chr2_-_32390801 | 8.79 |
ENST00000608489.1
|
RP11-563N4.1
|
RP11-563N4.1 |
| chr1_+_100598691 | 8.76 |
ENST00000370143.1
ENST00000370141.2 |
TRMT13
|
tRNA methyltransferase 13 homolog (S. cerevisiae) |
| chr2_-_70418032 | 8.76 |
ENST00000425268.1
ENST00000428751.1 ENST00000417203.1 ENST00000417865.1 ENST00000428010.1 ENST00000447804.1 ENST00000264434.2 |
C2orf42
|
chromosome 2 open reading frame 42 |
| chr12_-_51718436 | 8.75 |
ENST00000544402.1
|
BIN2
|
bridging integrator 2 |
| chr2_-_62081254 | 8.70 |
ENST00000405894.3
|
FAM161A
|
family with sequence similarity 161, member A |
| chr8_+_28747884 | 8.68 |
ENST00000287701.10
ENST00000444075.1 ENST00000403668.2 ENST00000519662.1 ENST00000558662.1 ENST00000523613.1 ENST00000560599.1 ENST00000397358.3 |
HMBOX1
|
homeobox containing 1 |
| chr19_+_3178736 | 8.67 |
ENST00000246115.3
|
S1PR4
|
sphingosine-1-phosphate receptor 4 |
| chr22_+_23134974 | 8.66 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr1_+_160765947 | 8.65 |
ENST00000263285.6
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
| chr4_-_153456153 | 8.63 |
ENST00000603548.1
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
| chr6_-_31514516 | 8.63 |
ENST00000303892.5
ENST00000483251.1 |
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
| chr14_-_106054659 | 8.60 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
| chr9_-_139094988 | 8.59 |
ENST00000371746.3
|
LHX3
|
LIM homeobox 3 |
| chr6_-_99873145 | 8.58 |
ENST00000369239.5
ENST00000438806.1 |
PNISR
|
PNN-interacting serine/arginine-rich protein |
| chr8_+_24771265 | 8.57 |
ENST00000518131.1
ENST00000437366.2 |
NEFM
|
neurofilament, medium polypeptide |
| chr17_-_27278304 | 8.56 |
ENST00000577226.1
|
PHF12
|
PHD finger protein 12 |
| chr14_-_81687197 | 8.55 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
| chr2_-_62733476 | 8.53 |
ENST00000335390.5
|
TMEM17
|
transmembrane protein 17 |
| chr20_+_44563267 | 8.53 |
ENST00000372409.3
|
PCIF1
|
PDX1 C-terminal inhibiting factor 1 |
| chr19_+_49866851 | 8.50 |
ENST00000221498.2
ENST00000596402.1 |
DKKL1
|
dickkopf-like 1 |
| chr19_+_5623186 | 8.50 |
ENST00000538656.1
|
SAFB
|
scaffold attachment factor B |
| chr6_+_142468361 | 8.47 |
ENST00000367630.4
|
VTA1
|
vesicle (multivesicular body) trafficking 1 |
| chr11_+_57365150 | 8.47 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
| chr12_+_6930703 | 8.46 |
ENST00000311268.3
|
GPR162
|
G protein-coupled receptor 162 |
Network of associatons between targets according to the STRING database.
First level regulatory network of PAX5
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.7 | 30.8 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 7.5 | 7.5 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 7.2 | 36.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 6.8 | 27.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 6.4 | 19.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 6.4 | 38.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 6.3 | 6.3 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 6.3 | 25.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 6.1 | 18.2 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 5.9 | 17.7 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 5.5 | 5.5 | GO:0045937 | positive regulation of phosphorus metabolic process(GO:0010562) positive regulation of phosphate metabolic process(GO:0045937) |
| 5.5 | 5.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 5.4 | 16.1 | GO:1904647 | response to rotenone(GO:1904647) |
| 5.2 | 15.6 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 5.0 | 5.0 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
| 4.9 | 4.9 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
| 4.7 | 14.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 4.7 | 32.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 4.6 | 13.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 4.6 | 83.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 4.6 | 32.3 | GO:0035624 | receptor transactivation(GO:0035624) |
| 4.4 | 13.2 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 4.2 | 4.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 4.2 | 12.6 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 4.2 | 25.0 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 4.0 | 12.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 4.0 | 59.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 3.8 | 11.4 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 3.7 | 3.7 | GO:0060022 | hard palate development(GO:0060022) |
| 3.7 | 7.3 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 3.6 | 18.2 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 3.6 | 3.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 3.6 | 10.8 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 3.5 | 14.2 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 3.5 | 17.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 3.5 | 7.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 3.5 | 3.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 3.4 | 3.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 3.4 | 10.2 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 3.4 | 17.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 3.3 | 19.9 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 3.3 | 13.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 3.3 | 3.3 | GO:0031297 | replication fork processing(GO:0031297) |
| 3.2 | 9.7 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 3.2 | 6.4 | GO:0009636 | response to toxic substance(GO:0009636) |
| 3.2 | 9.6 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 3.2 | 12.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 3.2 | 25.3 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 3.1 | 9.3 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 3.1 | 6.2 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 3.0 | 12.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 3.0 | 9.0 | GO:2000777 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 3.0 | 8.9 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 2.9 | 5.9 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 2.9 | 2.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 2.9 | 11.6 | GO:1902075 | cellular response to salt(GO:1902075) |
| 2.9 | 8.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 2.9 | 8.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 2.9 | 2.9 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 2.8 | 2.8 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 2.8 | 14.1 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 2.8 | 400.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 2.8 | 11.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 2.8 | 8.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 2.8 | 11.1 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 2.7 | 11.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 2.7 | 13.7 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 2.7 | 10.9 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 2.7 | 8.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 2.7 | 10.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 2.7 | 8.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 2.7 | 8.0 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 2.7 | 8.0 | GO:0071168 | protein localization to chromatin(GO:0071168) |
| 2.7 | 8.0 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 2.7 | 2.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 2.6 | 10.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 2.6 | 7.9 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 2.6 | 13.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 2.6 | 7.8 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 2.6 | 2.6 | GO:0034694 | response to prostaglandin(GO:0034694) |
| 2.6 | 7.7 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 2.6 | 5.1 | GO:0002434 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
| 2.6 | 20.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 2.6 | 20.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 2.6 | 7.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 2.6 | 7.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.5 | 7.6 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 2.5 | 12.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 2.5 | 10.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 2.5 | 10.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 2.5 | 25.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 2.5 | 12.4 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
| 2.4 | 4.9 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 2.4 | 16.9 | GO:0045007 | depurination(GO:0045007) |
| 2.4 | 9.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 2.4 | 2.4 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 2.4 | 33.4 | GO:0015671 | oxygen transport(GO:0015671) |
| 2.4 | 11.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 2.4 | 7.1 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 2.4 | 7.1 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 2.4 | 14.1 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 2.3 | 7.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 2.3 | 2.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 2.3 | 7.0 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 2.3 | 6.9 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 2.3 | 4.6 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 2.3 | 13.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 2.3 | 2.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 2.3 | 6.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 2.3 | 13.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 2.2 | 13.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 2.2 | 11.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 2.2 | 6.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 2.2 | 6.6 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 2.2 | 8.8 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 2.2 | 8.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 2.2 | 4.4 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 2.2 | 8.7 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 2.1 | 4.3 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 2.1 | 6.4 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 2.1 | 6.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 2.1 | 48.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 2.1 | 8.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 2.1 | 10.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 2.1 | 10.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 2.1 | 35.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 2.1 | 6.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 2.1 | 2.1 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 2.1 | 2.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 2.1 | 24.6 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 2.0 | 8.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 2.0 | 18.4 | GO:0015747 | urate transport(GO:0015747) |
| 2.0 | 10.1 | GO:0080009 | mRNA methylation(GO:0080009) |
| 2.0 | 6.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 2.0 | 6.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 2.0 | 4.0 | GO:0006473 | protein acetylation(GO:0006473) |
| 2.0 | 5.9 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 2.0 | 3.9 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 2.0 | 11.7 | GO:0051012 | microtubule sliding(GO:0051012) |
| 2.0 | 7.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 1.9 | 9.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 1.9 | 5.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.9 | 3.9 | GO:1904306 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 1.9 | 1.9 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 1.9 | 5.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.9 | 1.9 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 1.9 | 15.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.9 | 3.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 1.9 | 19.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.9 | 1.9 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 1.9 | 5.7 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
| 1.9 | 13.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 1.9 | 11.3 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 1.9 | 9.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 1.9 | 1.9 | GO:0045056 | transcytosis(GO:0045056) |
| 1.9 | 7.4 | GO:0033590 | response to cobalamin(GO:0033590) |
| 1.9 | 5.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 1.8 | 7.4 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 1.8 | 5.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
| 1.8 | 5.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 1.8 | 3.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.8 | 10.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 1.8 | 23.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 1.8 | 3.6 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
| 1.8 | 5.4 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 1.8 | 8.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 1.8 | 3.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 1.8 | 3.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.8 | 28.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 1.8 | 3.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 1.7 | 7.0 | GO:0048241 | epinephrine transport(GO:0048241) |
| 1.7 | 3.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 1.7 | 5.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.7 | 5.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 1.7 | 3.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 1.7 | 5.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 1.7 | 30.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 1.7 | 5.1 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 1.7 | 1.7 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 1.7 | 3.4 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 1.7 | 6.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 1.7 | 18.5 | GO:0033227 | dsRNA transport(GO:0033227) |
| 1.7 | 11.8 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 1.7 | 3.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 1.7 | 5.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 1.7 | 6.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 1.7 | 3.3 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 1.7 | 8.3 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
| 1.6 | 6.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 1.6 | 14.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 1.6 | 3.3 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 1.6 | 4.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 1.6 | 11.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.6 | 3.2 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 1.6 | 11.2 | GO:0034644 | cellular response to UV(GO:0034644) |
| 1.6 | 3.2 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.6 | 4.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 1.6 | 1.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 1.6 | 4.8 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 1.6 | 19.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 1.6 | 4.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.6 | 9.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 1.6 | 4.7 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 1.6 | 14.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
| 1.6 | 12.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 1.6 | 6.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 1.6 | 3.1 | GO:0001556 | oocyte maturation(GO:0001556) |
| 1.6 | 1.6 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 1.6 | 4.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 1.6 | 4.7 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 1.6 | 23.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 1.6 | 4.7 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 1.6 | 4.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.6 | 9.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 1.6 | 4.7 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 1.6 | 4.7 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 1.5 | 4.6 | GO:0035878 | nail development(GO:0035878) |
| 1.5 | 4.6 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
| 1.5 | 6.2 | GO:0021914 | signal transduction downstream of smoothened(GO:0007227) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) intraciliary anterograde transport(GO:0035720) |
| 1.5 | 9.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 1.5 | 1.5 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 1.5 | 3.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 1.5 | 3.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 1.5 | 7.6 | GO:0097338 | response to clozapine(GO:0097338) |
| 1.5 | 6.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 1.5 | 4.5 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 1.5 | 1.5 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 1.5 | 4.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 1.5 | 4.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 1.5 | 4.4 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 1.5 | 4.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 1.5 | 1.5 | GO:0051085 | 'de novo' posttranslational protein folding(GO:0051084) chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 1.5 | 14.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.5 | 1.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 1.5 | 23.5 | GO:0044117 | growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
| 1.5 | 7.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 1.5 | 1.5 | GO:0046645 | positive regulation of gamma-delta T cell activation(GO:0046645) |
| 1.5 | 7.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.5 | 5.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 1.5 | 2.9 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 1.5 | 7.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 1.5 | 10.2 | GO:0009597 | detection of virus(GO:0009597) |
| 1.5 | 7.3 | GO:0030070 | insulin processing(GO:0030070) |
| 1.4 | 5.8 | GO:0051026 | chiasma assembly(GO:0051026) |
| 1.4 | 18.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 1.4 | 7.2 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.4 | 8.6 | GO:0060613 | fat pad development(GO:0060613) |
| 1.4 | 5.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.4 | 17.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 1.4 | 4.3 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
| 1.4 | 4.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.4 | 2.8 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 1.4 | 25.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 1.4 | 4.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.4 | 11.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 1.4 | 11.2 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.4 | 27.7 | GO:0097320 | membrane tubulation(GO:0097320) |
| 1.4 | 9.7 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 1.4 | 4.2 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 1.4 | 1.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 1.4 | 9.6 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 1.4 | 4.1 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 1.4 | 8.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 1.4 | 5.5 | GO:1901727 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 1.4 | 2.7 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
| 1.4 | 11.0 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 1.4 | 5.5 | GO:0048749 | compound eye development(GO:0048749) |
| 1.4 | 2.7 | GO:0048867 | stem cell fate determination(GO:0048867) |
| 1.4 | 9.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 1.3 | 4.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.3 | 4.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.3 | 5.4 | GO:0030242 | pexophagy(GO:0030242) |
| 1.3 | 4.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 1.3 | 1.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 1.3 | 1.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.3 | 2.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 1.3 | 1.3 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.3 | 34.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 1.3 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 1.3 | 25.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 1.3 | 3.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 1.3 | 2.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 1.3 | 3.9 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 1.3 | 9.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 1.3 | 15.4 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 1.3 | 2.6 | GO:0048865 | stem cell fate commitment(GO:0048865) |
| 1.3 | 11.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 1.3 | 3.8 | GO:0071529 | cementum mineralization(GO:0071529) |
| 1.3 | 7.6 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 1.3 | 7.6 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 1.3 | 2.5 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
| 1.3 | 3.8 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.3 | 5.0 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 1.3 | 8.8 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 1.3 | 7.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 1.2 | 13.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 1.2 | 10.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 1.2 | 7.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 1.2 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 1.2 | 1.2 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 1.2 | 2.4 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 1.2 | 6.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.2 | 6.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.2 | 4.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 1.2 | 14.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 1.2 | 4.8 | GO:0045575 | basophil activation(GO:0045575) |
| 1.2 | 6.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 1.2 | 3.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 1.2 | 4.8 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 1.2 | 1.2 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 1.2 | 4.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 1.2 | 3.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.2 | 5.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 1.2 | 1.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 1.2 | 3.5 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 1.2 | 15.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 1.2 | 5.8 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 1.2 | 2.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 1.2 | 13.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 1.2 | 5.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 1.1 | 3.4 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.1 | 4.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 1.1 | 4.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.1 | 9.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 1.1 | 3.4 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
| 1.1 | 2.3 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 1.1 | 1.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 1.1 | 15.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 1.1 | 2.2 | GO:0043967 | histone H4 acetylation(GO:0043967) |
| 1.1 | 10.1 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 1.1 | 4.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 1.1 |